Literature DB >> 9080377

Non-genomic mechanism of 17 beta-oestradiol-induced inhibition of contraction in mammalian vascular smooth muscle.

T Kitazawa1, E Hamada, K Kitazawa, A K Gaznabi.   

Abstract

17 beta-Oestradiol (E2) at 0.1-10 microM directly inhibited various tonic and phasic smooth muscle contractions. The mechanism(s) of oestrogen-induced inhibition of contraction was studied using intact and permeabilized strips and isolated single cells of smooth muscle. 2. In endothelium-denuded vascular smooth muscle, E2 attenuated high K(+)-induced force development and myosin light chain phosphorylation, and produced rapid and reversible relaxation. There were no significant differences in these inhibitory effects between tissue types (femoral artery vs. portal vein), species (rat vs. rabbit) or sexes. 3. The inhibitory potencies of several steroidal and non-steroidal oestrogen analogues were examined and their effects were for the most part stereo-specific. However, two steroids with negligible affinities for the nuclear oestrogen receptor also strongly inhibited high K(+)-induced contraction. 4. Genomic modulators including a protein synthesis inhibitor, an RNA synthesis inhibitor, and oestrogen receptor antagonists did not affect the inhibitory actions of E2. Inhibitors of cyclic nucleotide-dependent protein kinases did not reduce the E2 effect. 5. Ca2+ release from intracellular stores by agonists and by inositol 1,4,5-trisphosphate (IP3) does not appear to be modulated by E2. Neither pretreatment with ryanodine nor with thapsigargin affected the E2-induced inhibition of high K(+)-induced contraction. 6. E2 had no effect on either normal or GTP gamma S-increased Ca2+ sensitivity of the regulatory and contractile apparatus. 7. E2 and its analogues rapidly inhibited voltage-dependent L-type Ca2+ channel currents in isolated smooth muscle cells. Repetitive stimulation was not required for E2-induced inhibition of the currents. 8. This study strongly suggests that at pharmacological concentrations oestrogen primarily reduces Ca2+ influx through inhibition of L-type Ca2+ channels in a non-genomic manner and decreases myosin light chain phosphorylation and contraction of smooth muscle.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9080377      PMCID: PMC1159322          DOI: 10.1113/jphysiol.1997.sp021944

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  37 in total

1.  Determination of aqueous solubility and pKa values of estrogens.

Authors:  A R Hurwitz; S T Liu
Journal:  J Pharm Sci       Date:  1977-05       Impact factor: 3.534

2.  Nongenomic effects of 17 beta-estradiol on maturing human oocytes: relationship to oocyte developmental potential.

Authors:  J Tesarik; C Mendoza
Journal:  J Clin Endocrinol Metab       Date:  1995-04       Impact factor: 5.958

Review 3.  Signal transduction and regulation in smooth muscle.

Authors:  A P Somlyo; A V Somlyo
Journal:  Nature       Date:  1994-11-17       Impact factor: 49.962

4.  Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.

Authors:  O P Hamill; A Marty; E Neher; B Sakmann; F J Sigworth
Journal:  Pflugers Arch       Date:  1981-08       Impact factor: 3.657

5.  Uterine estrogen receptor binding of catecholestrogens and of estetrol (1,3,5(10)-estratriene-3,15alpha,16alpha,17beta-tetrol).

Authors:  C Martucci; J Fishman
Journal:  Steroids       Date:  1976-03       Impact factor: 2.668

6.  Agonist-dependent modulation of Ca2+ sensitivity in rabbit pulmonary artery smooth muscle.

Authors:  B Himpens; T Kitazawa; A P Somlyo
Journal:  Pflugers Arch       Date:  1990-09       Impact factor: 3.657

7.  Vascular effects of 17 beta-estradiol in male Sprague-Dawley rats.

Authors:  J Shan; L M Resnick; Q Y Liu; X C Wu; M Barbagallo; P K Pang
Journal:  Am J Physiol       Date:  1994-03

8.  Systemic and uterine responses to chronic infusion of estradiol-17 beta.

Authors:  R R Magness; C R Parker; C R Rosenfeld
Journal:  Am J Physiol       Date:  1993-11

9.  Nitrendipine block of cardiac calcium channels: high-affinity binding to the inactivated state.

Authors:  B P Bean
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

10.  Interaction of the antioestrogen ICI 164,384 with the oestrogen receptor.

Authors:  P J Weatherill; A P Wilson; R I Nicholson; P Davies; A E Wakeling
Journal:  J Steroid Biochem       Date:  1988       Impact factor: 4.292

View more
  30 in total

1.  Nongenomic inhibition of coronary constriction by 17ß-estradiol, 2-hydroxyestradiol, and 2-methoxyestradiol.

Authors:  Brent J F Hill; Senetibeb Gebre; Bonnie Schlicker; Renée Jordan; Sean Necessary
Journal:  Can J Physiol Pharmacol       Date:  2010-02       Impact factor: 2.273

2.  Greater antiarrhythmic activity of acute 17beta-estradiol in female than male anaesthetized rats: correlation with Ca2+ channel blockade.

Authors:  K L Philp; M Hussain; N F Byrne; M J Diver; G Hart; S J Coker
Journal:  Br J Pharmacol       Date:  2006-08-29       Impact factor: 8.739

3.  Prolonged bed rest impairs rapid CPI-17 phosphorylation and contraction in rat mesenteric resistance arteries to cause orthostatic hypotension.

Authors:  Toshio Kitazawa; Kazuyo Kitazawa
Journal:  Pflugers Arch       Date:  2017-07-17       Impact factor: 3.657

4.  Oestrogen confers cardioprotection by suppressing Ca2+/calmodulin-dependent protein kinase II.

Authors:  Y Ma; W T Cheng; S Wu; T M Wong
Journal:  Br J Pharmacol       Date:  2009-05-05       Impact factor: 8.739

5.  Estrogen receptors differentially regulate intracellular calcium handling in human nonasthmatic and asthmatic airway smooth muscle cells.

Authors:  Sangeeta Bhallamudi; Jennifer Connell; Christina M Pabelick; Y S Prakash; Venkatachalem Sathish
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-10-16       Impact factor: 5.464

6.  Influence of gender and the oestrous cycle on in vitro contractile responses of the rat urinary bladder to cholinergic stimulation.

Authors:  P A Longhurst; M Levendusky
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

Review 7.  Sex differences and sex steroids in lung health and disease.

Authors:  Elizabeth A Townsend; Virginia M Miller; Y S Prakash
Journal:  Endocr Rev       Date:  2012-01-12       Impact factor: 19.871

Review 8.  Contraceptive hormone use and cardiovascular disease.

Authors:  Chrisandra L Shufelt; C Noel Bairey Merz
Journal:  J Am Coll Cardiol       Date:  2009-01-20       Impact factor: 24.094

9.  Effects of 17beta-oestradiol on rat detrusor smooth muscle contractility.

Authors:  Aurora Valeri; Keith L Brain; John S Young; Giampietro Sgaragli; Federica Pessina
Journal:  Exp Physiol       Date:  2009-04-24       Impact factor: 2.969

10.  Menstruation angina: a case report.

Authors:  Wai Kah Choo
Journal:  J Med Case Rep       Date:  2009-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.